$ICEBIO News
Last published 4y ago
- 4y agoBTXNBIICEBIOBrooklyn ImmunoTherapeutics Announces Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewswireSAN DIEGO, April 15, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer
- 4y agoTSHAICEBIOTaysha Gene Therapies Added to the ICE Biotechnology IndexBusiness WireTaysha Gene Therapies, Inc. (NASDAQ:TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare
- 4y agoBTXICEBIOBrooklyn ImmunoTherapeutics Added to ICE Biotechnology IndexGlobeNewswireNEW YORK, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, bl